Overview


According to FutureWise analysis the market for Fluoroscopy Equipment in 2023 is US$ 6.83 billion, and is expected to reach US$ 10.11 billion by 2031 at a CAGR of 5.02%.

The main factors driving the growth of the market are the benefits of FPDs over image intensifiers, increasing geriatric population, awareness activities, rising cases of chronic diseases and the use of fluoroscopy in pain management. In addition, the favorable reimbursement policy for analog radiography systems is augmenting the market growth. The rapid adoption of hand-held fluoroscopes due to its efficient facilities is creating a lucrative opportunity for the manufacturers.
The market is classified into product, application, and region. Based on products, fluoroscopy systems are expected to dominate the market. The technological advancements in fixed C-arms and growing use of fluoroscopic imaging for interventional procedures and imaging for diagnosis is spurring the market. Fluoroscope systems offer various benefits such as radiation sensitivity, optical magnification, and high portability. Furthermore, they provide better clarity and stability of images. Other advantages for opting fluoroscope systems are high portability, optical magnification, x-ray recording capability and real-time tracking of images. Such factors have bolstered the market.

Based on application, surgical applications is expected to hold vast shares of the market. Surgical applications consist of orthopaedic and trauma, cardiovascular, neurosurgeries and gastrointestinal surgeries. Growing prevalence of cardiovascular diseases has led to a demand for highly efficient diagnostic imaging tools. Fluoroscopy is most frequently performed with procedures such as coronary angiography, radiographic catheter ablation, and diagnosis electrophysiology studies. The growing number of conferences and exhibitions by prominent players and manufacturers to promote fluoroscopy instruments is stimulating the market. The growing importance of anatomy visualization in emergency medicine is also driving the market. Fluoroscopy facilities can be used during cardiac catheterization since it performs as an adjunct to examine the presence of arterial blockages.

Based on regions, North America dictates the market growth. Government initiatives to promote efficient treatment facilities is boosting the presence of the market in the region. For example, the FDA launched an initiative to reduce the radiation exposure of medical imaging. The initiative has resulted in an enhanced and efficient treatment for multiple surgeries. Growing preference of private and public healthcare organizations to promote advanced imaging instruments is resulting in more adoption of fluoroscopy instruments in the region. The rising number of obese population coupled with growing inclination towards minimally invasive surgeries have stimulated the market in the region. Asia-Pacific region is also expected to show substantial growth owing to the strong economic development of countries like China and India. The growing number of geriatric population in nations like China and Japan is playing an instrumental role in the expansion of the market in the region.

  • Hologic
  • Carestream Health
  • Adani Systems
  • Agfa-Gevaert Group
  • Hitachi
  • Ziehm Imaging
  • Philips
  • GE Healthcare
  • Siemens Healthineers
  • Shimadzu
  • Lepu Medical Technology

(Note: The list of the major players will be updated with the latest market scenario and trends)

Product launches are bolstering the market. Siemens Healthineers launched Artis icono biplane in 2019. The Artis icono biplane is an angiography system which consists of special functions for neuroradiology.
Strategic collaborations aiming towards the advancements of the latest products is propelling the market. GE Healthcare signed a 7-year collaborative agreement with Temple University Health System to expand services related to radiology. The collaboration played an important role in eliminating restraints like cost control and reimbursement related to medical imaging.

By Product

  • Fixed C-arms
  • Fluoroscopy Systems
    • Remote Controlled Systems
    • Patient-Side Controlled Systems
  • Mobile C-arms

By Application

  • Diagnostic Applications
    • Cardiology
    • Gastroenterology
    • Urology and Nephrology
  • Surgical Applications
    • Orthopedic and Trauma Surgeries
    • Neo Surgeries
    • Cardiovascular Surgeries
    • Gastrointestinal Surgeries

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Latest technological advancements in the form of rotational angiography, flat-panel detector integrated with computed tomography will play an instrumental role in the expansion of the market. Surgical procedures are expected to grow substantially owing to benefits such as higher visibility, dose reduction, and minimal trauma and invasion. Orthopedics segment is anticipated to witness substantial growth owing to the rising adoption of fluoroscopy instruments in urgent care clinics, imaging centers, and orthopedic clinics.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global fluoroscopy equipment market by product, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financial and core competencies

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Fluoroscopy Equipment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Fluoroscopy Equipment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Fluoroscopy Equipment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Fluoroscopy Equipment Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fixed C-arms
        2. Fluoroscopy Systems
         2.1. Remote Controlled Systems
         2.2. Patient-Side Controlled Systems
        3. Mobile C-arms

  • 8.   Fluoroscopy Equipment Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Applications
         1.1. Cardiology
         1.2. Gastroenterology
         1.3. Urology and Nephrology
        2. Surgical Applications
         2.1. Orthopedic and Trauma Surgeries
         2.2. Neo Surgeries
         2.3. Cardiovascular Surgeries
         2.4. Gastrointestinal Surgeries

  • 9.   North America Fluoroscopy Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Fluoroscopy Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Fluoroscopy Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Fluoroscopy Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Fluoroscopy Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hologic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Carestream Health
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Adani Systems
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Agfa-Gevaert Group
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hitachi
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Ziehm Imaging
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Philips
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GE Healthcare
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Siemens Healthineers
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Shimadzu
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Lepu Medical Technology
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients